Clinical predictors of relapse and severe disease phenotype in children with non-systemic juvenile idiopathic arthritis. [PDF]
Sarısoy D +7 more
europepmc +1 more source
Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy. [PDF]
Freeman WJ, Rife EC, Cron RQ.
europepmc +1 more source
First Description of Nonlupus Full-House Nephropathy in Systemic Juvenile Idiopathic Arthritis Responsive to High-Dose Tocilizumab. [PDF]
Jacobs L +7 more
europepmc +1 more source
A Bullseye for Children With Systemic Juvenile Idiopathic Arthritis [PDF]
openaire +2 more sources
Case Report: Ruxolitinib for systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome: two pediatric cases and literature review. [PDF]
Liu H, Wang Z, Zhang W.
europepmc +1 more source
Reliability and Construct Validity of the Physician's Global Assessment of Lung Disease in Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. [PDF]
Rife E +14 more
europepmc +1 more source
Efficacy and Safety of Firsekibart in Treatment of Active Systemic Juvenile Idiopathic Arthritis: A Randomized Phase 2 Study. [PDF]
Li C +19 more
europepmc +1 more source
tRF-30-FP18LPMBQ4NK in Systemic Juvenile Idiopathic Arthritis: A Promising Diagnostic and Disease Activity Biomarker. [PDF]
Huang J +6 more
europepmc +1 more source
Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practice. [PDF]
Lamers HC +6 more
europepmc +1 more source
Invasive Rhinocerebral Mucormycosis Is a Rare Complication in Systemic Juvenile Idiopathic Arthritis Patient [PDF]
Petrova AN +6 more
europepmc +1 more source

